Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 3
1956 3
1957 2
1958 7
1959 8
1960 3
1962 3
1963 5
1964 4
1965 12
1966 8
1967 9
1968 13
1969 14
1970 15
1971 13
1972 12
1973 16
1974 16
1975 22
1976 14
1977 21
1978 15
1979 17
1980 38
1981 40
1982 37
1983 48
1984 35
1985 43
1986 36
1987 43
1988 55
1989 51
1990 70
1991 70
1992 75
1993 75
1994 87
1995 84
1996 95
1997 87
1998 138
1999 101
2000 93
2001 120
2002 128
2003 139
2004 133
2005 154
2006 130
2007 121
2008 121
2009 107
2010 117
2011 123
2012 156
2013 173
2014 202
2015 184
2016 165
2017 190
2018 210
2019 198
2020 237
2021 271
2022 232
2023 189
2024 88
2025 2

Text availability

Article attribute

Article type

Publication date

Search Results

5,007 results

Results by year

Filters applied: . Clear all
Page 1
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society.
Sabbag A, Essayagh B, Barrera JDR, Basso C, Berni A, Cosyns B, Deharo JC, Deneke T, Di Biase L, Enriquez-Sarano M, Donal E, Imai K, Lim HS, Marsan NA, Turagam MK, Peichl P, Po SS, Haugaa KH, Shah D, de Riva Silva M, Bertrand P, Saba M, Dweck M, Townsend SN, Ngarmukos T, Fenelon G, Santangeli P, Sade LE, Corrado D, Lambiase P, Sanders P, Delacrétaz E, Jahangir A, Kaufman ES, Saggu DK, Pierard L, Delgado V, Lancellotti P. Sabbag A, et al. Among authors: imai k. Europace. 2022 Dec 9;24(12):1981-2003. doi: 10.1093/europace/euac125. Europace. 2022. PMID: 35951656 Free article. No abstract available.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. Among authors: imai k. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Among authors: imai k. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
Response.
Yabuuchi Y, Imai K, Hotta K, Ito S, Kishida Y, Ono H. Yabuuchi Y, et al. Among authors: imai k. Gastrointest Endosc. 2021 Aug;94(2):434-435. doi: 10.1016/j.gie.2021.04.011. Gastrointest Endosc. 2021. PMID: 34271999 No abstract available.
Response.
Minamide T, Kawata N, Maeda Y, Yoshida M, Yamamoto Y, Takada K, Kishida Y, Ito S, Imai K, Hotta K, Sato J, Ishiwatari H, Matsubayashi H, Ono H. Minamide T, et al. Among authors: imai k. Gastrointest Endosc. 2023 Jul;98(1):138-139. doi: 10.1016/j.gie.2023.03.002. Gastrointest Endosc. 2023. PMID: 37331766 No abstract available.
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Balar AV, Castellano DE, Grivas P, Vaughn DJ, Powles T, Vuky J, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Necchi A, Petrylak DP, Plimack ER, Xu JZ, Imai K, Moreno BH, Bellmunt J, de Wit R, O'Donnell PH. Balar AV, et al. Among authors: imai k. Ann Oncol. 2023 Mar;34(3):289-299. doi: 10.1016/j.annonc.2022.11.012. Epub 2022 Dec 6. Ann Oncol. 2023. PMID: 36494006 Free article. Clinical Trial.
Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer.
Kitamura F, Semba T, Yasuda-Yoshihara N, Yamada K, Nishimura A, Yamasaki J, Nagano O, Yasuda T, Yonemura A, Tong Y, Wang H, Akiyama T, Matsumura K, Uemura N, Itoyama R, Bu L, Fu L, Hu X, Wei F, Mima K, Imai K, Hayashi H, Yamashita YI, Miyamoto Y, Baba H, Ishimoto T. Kitamura F, et al. Among authors: imai k. JCI Insight. 2023 Oct 23;8(20):e163022. doi: 10.1172/jci.insight.163022. JCI Insight. 2023. PMID: 37733442 Free PMC article.
Plastic vasomotion entrainment.
Sasaki D, Imai K, Ikoma Y, Matsui K. Sasaki D, et al. Among authors: imai k. Elife. 2024 Apr 17;13:RP93721. doi: 10.7554/eLife.93721. Elife. 2024. PMID: 38629828 Free PMC article.
The Primary Immunodeficiency Database in Japan.
Mitsui-Sekinaka K, Sekinaka Y, Endo A, Imai K, Nonoyama S. Mitsui-Sekinaka K, et al. Among authors: imai k. Front Immunol. 2022 Jan 10;12:805766. doi: 10.3389/fimmu.2021.805766. eCollection 2021. Front Immunol. 2022. PMID: 35082792 Free PMC article. Review.
5,007 results